Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Axitinib in Metastatic Non-clear Cell Renal Cell Carcinoma Patients Previously Treated With Temsirolimus

NCT01798446 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT01798446
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01798446 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Axitinib in Metastatic Non-clear Cell Renal Cell Carcinoma Patients Previously Treated With Temsirolimus
Lead sponsor
Seoul National University Hospital
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2013
Completion date
December 31, 2016
Enrollment
41 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nonclear cell, renal cell carcinoma, temsirolimus resistance